Upadacitinib hemihydrate

2050057-56-0

CAS番号.: 2050057-56-0

化学名:

别名:

英語名:: Upadacitinib hemihydrate

英語别名:: Upadacitinib hemihydrate;ABT494 hemihydrate;ABT 494 hemihydrate;ABT-494 hemihydrate;Upadacitinib Hydrate;Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-";1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-

CBNumber:: CB29872273

化学式:: C17H21F3N6O2

分子量:: 398.39

MOL File:: 2050057-56-0.mol

物理性質

安全性情報

用途語

生産企業 73

Upadacitinib hemihydrate 物理性質

InChIKey:: VJSRYIXHEWRBKD-NFGOAHBONA-N

SMILES:: C([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|

安全性情報

Upadacitinib hemihydrate 価格

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入

Upadacitinib hemihydrate 化学特性,用途語,生産方法

臨床応用

RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). RINVOQ may be used as monotherapy or in combination with methotrexate. Each prolonged-release tablet (RINVOQ 15 mg prolonged-release tablets.) contains upadacitinib hemihydrate, equivalent to 15 mg of upadacitinib.

Upadacitinib hemihydrate 上流と下流の製品情報

原材料

準備製品

Upadacitinib hemihydrate 生産企業

Global( 73)Suppliers

名前	電話番号	電子メール	国籍	製品カタログ	優位度
TAIZHOU YUXIN BIOTECHNOLOGY CO,.LTD	+86-576-88902229;+86-0576-88902229 +8613968687450	yuxin@yuxchem.com	China	158	58
Taizhou Creating Bio-pharm co., ltd.	+8613586099526	post@creatingbiopharm.com	China	217	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49391	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471	sales@sarms4muscle.com	China	10522	58
Heading （Nanjing）Pharmtechnologies Co., Ltd.	+86-25-58467899-832 +86-13382406280	liucheng@headingpharm.com	China	46	58
ShenZhen Trendseen Biological Technology Co.,Ltd.	13417589054	trendseenbio@gmail.com	China	11681	58
SUZHOU SENFEIDA CHEMICAL CO.,LTD	+86-0512-83500002 +8615195660023	sales@senfeida.com	China	13707	58
Jiangxi Chiyan Biopharmaceutical Technology Co.,Ltd.	+86-18616643091 +86-18616643091	info@rochipharma.com	China	246	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8617865335152	Mandy@hangyubiotech.com	China	10978	58
Wuhan Jingkang en Biomedical Technology Co., Ltd	+8613720134139	orders@jknbiochem.com	China	4692	58

2050057-56-0
1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-
Upadacitinib hemihydrate
Upadacitinib Hydrate
Cinchonanium, 1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'- [[3-(trifluoromethyl)phenyllmethyl},bromide(1:2), (8a,9R)-"
ABT 494 hemihydrate
ABT494 hemihydrate
ABT-494 hemihydrate